Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Study Comparing A Chemotherapy With Cisplatin And Etoposide To A Etoposide Regimen Without Cisplatin For Patients With Extensive Small-Cell Lung Cancer

NCT00658580 is registered in ClinicalTrials.gov with European Lung Cancer Working Party as lead sponsor.

NCT NCT00658580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00658580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Study Comparing A Chemotherapy With Cisplatin And Etoposide To A Etoposide Regimen Without Cisplatin For Patients With Extensive Small-Cell Lung Cancer
Lead sponsor
European Lung Cancer Working Party
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2000
Completion date
February 28, 2015
Enrollment
361 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung carcinoma, extensive disease